Qingbao Guo

Dr. Qingbao Guo

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2024 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
QGQingbao Guo
Qingbao Guo
YFYan-Na Fan
Yan-Na Fan
MXManli Xie
Manli Xie
QWQian-Nan Wang
Qian-Nan Wang
JLJingjie Li
Jingjie Li
LDLian Duan
Lian Duan
Background: Systemic Lupus Erythematosus (SLE) is acknowledged for its significant influence on systemic health. This study sought to explore potential crosstalk genes, pathways, and immune cells in the relationship between SLE and moyamoya disease (MMD).Methods: We obtained data on SLE and MMD from the Gene Expression Omnibus (GEO) database. Differential expression analysis and weighted gene co-expression network analysis (WGCNA) were conducted to identify common genes. Subsequently, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed on these shared genes. Hub genes were further selected through the least absolute shrinkage and selection operator (LASSO) regression, and a receiver operating characteristic (ROC) curve was generated based on the results of this selection. Finally, single-sample Gene Set Enrichment Analysis (ssGSEA) was utilized to assess the infiltration levels of 28 immune cells in the expression profile and their association with the identified hub genes.Results: By intersecting the important module genes from WGCNA with the DEGs, the study highlighted CAMP, CFD, MYO1F, CTSS, DEFA3, NLRP12, MAN2B1, NMI, QPCT, KCNJ2, JAML, MPZL3, NDC80, FRAT2, THEMIS2, CCL4, FCER1A, EVI2B, CD74, HLA-DRB5, TOR4A, GAPT, CXCR1, LAG3, CD68, NCKAP1L, TMEM33, and S100P as key crosstalk genes linking SLE and MMD. GO analysis indicated that these shared genes were predominantly enriched in immune system process and immune response. LASSO analysis identified MPZL3 as the optimal shared diagnostic biomarkers for both SLE and MMD. Additionally, the analysis of immune cell infiltration revealed the significant involvement of activation of T and monocytes cells in the pathogenesis of SLE and MMD.Conclusion: This study is pioneering in its use of bioinformatics tools to explore the close genetic relationship between MMD and SLE. The genes CAMP, CFD, MYO1F, CTSS, DEFA3, NLRP12, MAN2B1, NMI, QPCT, KCNJ2, JAML, MPZL3, NDC80, FRAT2, THEMIS2, CCL4, FCER1A, EVI2B, CD74, HLA-DRB5, TOR4A, GAPT, CXCR1, LAG3, CD68, NCKAP1L, TMEM33, and S100P have been identified as key crosstalk genes that connect MMD and SLE. Activation of T and monocytes cells-mediated immune responses are proposed to play a significant role in the association between MMD and SLE.

12 May 2025 in European Journal of Neurology
Verified
Journal Article
Open access
JLJing‐Jie Li
Jing‐Jie Li
XWXiao‐Peng Wang
Xiao‐Peng Wang
QWQian‐Nan Wang
Qian‐Nan Wang
ZKZi‐Qing Kong
Zi‐Qing Kong
CHCong Han
Cong Han
LDLian Duan
Lian Duan
Background: Stroke in children is a global epidemic.Methods: Data on stroke, including incidence, DALYs, mortality, and associated risk factors from 1990 to 2021, were obtained from the Global Burden of Disease (GBD) study, 2021. Estimated annual percentage changes were calculated to evaluate changes in the age‐standardized rates of incidence (ASIR), DALYs (ASDR), and mortality (ASMR), as well as trends by age, sex, and sociodemographic index (SDI). Projections of DALYs to 2050 were made.Results: In 2021, there were 310,133 incident stroke cases, accounting for 24,807 deaths and 2,414,655 DALYs among children and adolescents. The global ASIR, ASDR, and ASMR for stroke were 11.8, 93.9, and 1.0 per 100,000 population, respectively. Middle‐to‐low‐SDI regions accounted for 81.6% of incident cases, 90.2% of DALYs, and 92.7% of deaths. A reversed V‐shaped association was observed between SDI and ASRs. Children < 1 year had the highest ASRs, with rates generally decreasing with age, and the highest incidence of hemorrhagic stroke. Adolescents aged 15–19 years had the highest incidence of ischemic stroke. Non‐optimal temperature contributed the most to the DALYs and death rates for stroke. By 2050, it is projected that 282,404 DALYs will be lost due to stroke.Conclusions: Stroke burden varies by the GBD region, country, age, sex, and SDI. Despite declines in ASRs, stroke remains a significant burden, especially in middle‐to‐low‐SDI regions, among children < 1 year, and among those with intracerebral hemorrhage. Non‐optimal temperature emerges as the leading modifiable risk factor for children stroke; targeted interventions can prevent this.

29 April 2025 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
QGQingbao Guo
Qingbao Guo
MXManli Xie
Manli Xie
XWXiaopeng Wang
Xiaopeng Wang
CHCong Han
Cong Han
GGGan Gao
Gan Gao
QGQingbao Guo
Qingbao Guo
Moyamoya disease (MMD) is a rare cerebrovascular disease in humans. Although early revascularization can improve symptoms, it cannot reverse the progression of the disease. The current diagnosis still relies on traditional a Digital Subtraction Angiography (DSA) examination, which is invasive and expensive, leading to delayed diagnosis and affecting treatment timing and patient prognosis. The ability to diagnose MMD early and develop personalized treatment plans can significantly improve the prognosis of patients. Here, we have introduced the research on MMD biomarkers. By integrating proteomics and metabolomics data, we have successfully identified over 1700 features from more than 60 serum samples collected at the onset of symptoms in MMD patients. We use multiple computational strategies to interpret complex information in serum, providing a comprehensive perspective for early diagnosis of MMD. Diagnostic ability of our biomarker is significantly better than previous studies, especially when used in combination. In the study of molecular mechanisms, we found that the ferroptosis pathway was significant disruption in MMD patients, which was also confirmed by transcriptomics data. Finally, we validated the metabolites and proteins associated with ferroptosis pathways, as well as the biomarkers screened by machine learning, using another independent MMD cohort. Our research provides important clues for the diagnosis of MMD, and this assay can identify MMD early, thereby promoting stronger monitoring and intervention.

12 June 2025 in International Journal of Surgery
Verified
Journal Article
Open access
QGQingbao Guo
Qingbao Guo
MXManli Xie
Manli Xie
HWHui Wang
Hui Wang
QWQian-Nan Wang
Qian-Nan Wang
QGQingbao Guo
Qingbao Guo
LDLian Duan
Lian Duan
Background: Pediatric hemorrhagic moyamoya disease (MMD) is rare, and currently, no risk model exists for predicting preoperative bleeding. We aimed to develop a nomogram to predict the preoperative bleeding risk in children with MMD. Methods: We retrospectively analyzed data from 1350 children diagnosed with MMD from January 2004 to December 2022 at our institution. After applying propensity score matching (PSM), 392 patients were selected for analysis, comprising 98 with hemorrhagic MMD and 294 with non-hemorrhagic MMD. The cohort was divided into training and internal validation cohorts. To construct the nomogram, variable selection was performed using the least absolute shrinkage and selection operator (LASSO), and the model was externally validated with an independent cohort of 70 children. We utilized multivariate logistic regression to determine odds ratios and 95% confidence intervals for preoperative bleeding risk. A predictive nomogram was then developed from the logistic model, with polynomial equations to quantify risk. The model’s effectiveness was evaluated using receiver operating characteristic curves, calibration plots, and decision curve analyses (DCAs). Inflection points for continuous variables were identified using restricted cubic spline (RCS) analysis. Results: The LASSO model demonstrated superior discriminative performance compared to six alternative models, achieving area under the curve values of 91.5% in the training cohort, 78.4% in the internal validation cohort, and 91.2% in the external validation cohort. Based on variables selected through the LASSO model, we developed a nomogram incorporating three critical factors: age at onset ( P = 0.001), anterior choroidal artery grades 1 ( P = 0.047) and 2 ( P < 0.001), and posterior communicating artery grades 1 ( P = 0.002) and 2 ( P = 0.032). Calibration plots indicated strong concordance between predicted and observed outcomes across both training and validation cohorts (Hosmer–Lemeshow P = 0.503), affirming the model’s accuracy. Additionally, DCA highlighted the nomogram’s clinical utility by effectively identifying patients at high risk. RCS analysis revealed age 8 as a pivotal inflection point ( P < 0.05), marking a significant increase in the risk of preoperative bleeding beyond this age. Conclusion: The nomogram demonstrated high accuracy in predicting preoperative bleeding risk in pediatric patients with MMD. This predictive accuracy may enhance preoperative evaluation by surgeons, allowing for more proactive intervention and intensified monitoring of children at elevated risk of bleeding, thereby improving patient outcomes.

17 June 2025 in Journal of the American Heart Association
Verified
Journal Article
Open access
QGQingbao Guo
Qingbao Guo
MXManli Xie
Manli Xie
HJHuanhuan Ji
Huanhuan Ji
QWQian‐Nan Wang
Qian‐Nan Wang
QGQingbao Guo
Qingbao Guo
LDLian Duan
Lian Duan
Background: Although hypertension is prevalent in adults with moyamoya disease (MMD) and intracranial hemorrhage significantly worsens prognosis, the impact of hypertension on long‐term outcomes after encephaloduroarteriosynangiosis in hemorrhagic MMD remains unclear; this retrospective cohort study used propensity score matching to compare outcomes between hypertensive and nonhypertensive patients and preliminarily assess the role of blood pressure management. Methods: After propensity score matching, long‐term outcomes post‐ encephaloduroarteriosynangiosis in patients with hemorrhagic MMD with hypertension from January 2010 to December 2018 were analyzed. The clinical and radiological data were collected. Kaplan–Meier curves evaluated the relationship between recurrence‐free survival, overall survival (OS), and hypertension. Univariate and multivariate Cox regression assessed independent factors influencing hematoma recurrence‐free survival and OS. Subgroup analysis of patients with hemorrhagic MMD with hypertension assessed the impact of different blood management on long‐term outcomes. Results: Kaplan–Meier curves showed a significant correlation between hypertension and decreased hematoma recurrence‐free survival ( P =0.004) and OS ( P =0.014) during follow‐up. The 5‐year recurrence‐free survival rate did not significantly differ between hypertensive and nonhypertensive groups ( P =0.77). Hypertension was associated with reduced 10‐year hematoma recurrence‐free survival ( P =0.004) and OS ( P =0.014). In multivariate analysis, hypertension ( P =0.015), perioperative complications ( P =0.003), and choroidal anastomosis ( P =0.0008) significantly influenced hematoma recurrence‐free survival. Analysis of OS revealed significant differences for hypertension ( P =0.018), follow‐up duration ( P <0.001), choroidal anastomosis ( P =0.041), and initial mRS ( P <0.001). Subgroup analysis showed that optimal blood pressure management significantly reduced hematoma recurrence ( P =0.049) but did not improve OS ( P =0.31). Conclusions: This study highlights significant differences in hematoma recurrence‐free survival and OS between patients with hemorrhagic MMD with and without hypertension. A subgroup analysis of those with hypertension showed that optimal blood pressure control notably lowered hematoma recurrence but did not improve OS. For patients with hemorrhagic MMD with hypertension, optimizing blood pressure alone may be insufficient, emphasizing the importance of personalized integrated strategies for this patient subgroup.

24 February 2026 in Neurology
Verified
Journal Article
Closed access
QGQingbao Guo
Qingbao Guo
MXManli Xie
Manli Xie
JWJingchun Wang
Jingchun Wang
CZChangfa Zhao
Changfa Zhao
ZWZhenhua Wang
Zhenhua Wang
LDLian Duan
Lian Duan
Pediatric hemorrhagic moyamoya disease (MMD) is a critical subtype associated with high morbidity; however, hemorrhage-specific prognostic factors remain poorly defined. The aim of this study was to define the clinical course, identify factors associated with hemorrhagic presentation and recurrence, and evaluate long-term outcomes in a large pediatric cohort. This retrospective cohort study included children diagnosed with MMD between 2003 and 2023. Hemorrhagic MMD was defined as acute intracranial hemorrhage on CT/MRI within 72 hours of symptom onset, excluding traumatic or aneurysmal causes. Standardized data collection encompassed Suzuki staging, posterior communicating artery (PcomA) and anterior choroidal artery (AChA) dilatation, modified Rankin Scale (mRS) scores at admission and follow-up, and recurrence events. Multivariable logistic regression and Cox proportional hazards models were used to identify factors associated with hemorrhagic MMD and stroke recurrence. Among 1,446 pediatric patients with MMD, 117 had hemorrhagic presentation. The hemorrhagic cohort was significantly older (mean age 10.9 ± 4.1 years vs 7.6 ± 4.5 years, p < 0.001) and had a higher proportion of female patients (68.4% vs 50.0%, p < 0.001). Factors independently associated with hemorrhagic MMD included AChA dilatation (adjusted odds ratio [aOR] 5.95, 95% CI 3.56-9.92, p < 0.001), PcomA dilatation (aOR 4.23, 95% CI 2.48-7.20, p < 0.001), and admission mRS score ≥2 (aOR 2.38, 95% CI 1.44-3.96, p < 0.001). The hemorrhagic group showed higher rates of hematoma recurrence (7.7% vs 0.8%, p < 0.001). AChA dilatation was strongly associated with recurrent hematoma (hazard ratio [HR] 8.85, 95% CI 3.06-25.58, p < 0.001). Admission mRS score ≥2 was significantly associated with all recurrence subtypes: stroke (HR 13.32), hematoma (HR 5.58), and infarction (HR 52.16; all p ≤ 0.002). The Kaplan-Meier analysis confirmed markedly reduced 8-year hematoma recurrence-free survival in hemorrhagic MMD (50% vs >80% in ischemic, p < 0.0001). Hemorrhagic MMD is an aggressive subtype characterized by posterior collateral vulnerability, female predominance, and older age. Admission mRS score ≥2 and AChA dilatation are key factors strongly associated with adverse outcomes. Conventional angiographic classification does not demonstrate a significant association with hemorrhage outcome; assessment of the posterior circulation is critical for stratifying patient outcomes and guiding early intervention.